XyloCor Therapeutics
Series B
Gene therapy for cardiovascular diseases
XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.
Founders
R
LinkedIn ↗
News & Funding
Similar Startups
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
Freenome
Blood test to detect colorectal cancer
Mira
Hormone monitor and supplements
Janux Therapeutics
Immunotherapy to fight tumors
Epikast
Series B
Engage patients and health providers
ModMed
Software for specialty medical practices